Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Testing effectiveness (Phase 2)Study completedNCT01432574
What this trial is testing

Study of Gardasil in Mid-Adult Males (MAM)

Who this might be right for
Human Papillomavirus
H. Lee Moffitt Cancer Center and Research Institute 150
Testing effectiveness (Phase 2)Study completedNCT02199691
What this trial is testing

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,715
Large-scale testing (Phase 3)Study completedNCT01462357
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,079
Testing effectiveness (Phase 2)Study completedNCT00680147
What this trial is testing

Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers

Who this might be right for
HPV
Syracuse University 614
Large-scale testing (Phase 3)Study completedNCT02993757
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 528
Post-approval studies (Phase 4)Active Not RecruitingNCT05557370
What this trial is testing

Immunogenicity of HPV Vaccine in Transplant Recipients.

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Medical College of Wisconsin 30
Large-scale testing (Phase 3)Study completedNCT03431246
What this trial is testing

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Who this might be right for
Human Papillomavirus Vaccines
Laval University 32
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT01553994
What this trial is testing

Effectiveness Study of Gardasil on Condyloma

Who this might be right for
CondylomaGenital Warts
Lisen Arnheim Dahlstrom 500,000
Not applicableStudy completedNCT03083249
What this trial is testing

Gardasil Knowledge

Who this might be right for
HPV
Sarah Hostetter, MD 50
Testing effectiveness (Phase 2)Looking for participantsNCT06624839
What this trial is testing

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Who this might be right for
Human Papilloma VirusAnal DysplasiaHIV
University of Maryland, Baltimore 120
Not applicableStudy completedNCT01299714
What this trial is testing

Community Awareness, Resources and Education (CARE II): Project 3

Who this might be right for
Uterine Cervical Cancer
Ohio State University Comprehensive Cancer Center 191
Not applicableStudy completedNCT01062074
What this trial is testing

GARDASIL Reexamination Study (V501-059)

Who this might be right for
Human Papillomavirus (HPV) Infection
Merck Sharp & Dohme LLC 3,605
Large-scale testing (Phase 3)Study completedNCT03158220
What this trial is testing

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 1,212
Not applicableStudy completedNCT01343485
What this trial is testing

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Who this might be right for
GARDASIL Vaccination
Planned Parenthood Federation of America 365
Large-scale testing (Phase 3)Study completedNCT00090285
What this trial is testing

An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)

Who this might be right for
Condylomata Acuminata
Merck Sharp & Dohme LLC 4,065
Not applicableStudy completedNCT02811068
What this trial is testing

Observational Follow up of Prior HPV Vaccinees

Who this might be right for
Human Papillomavirus Virus
Public Health England 93
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Large-scale testing (Phase 3)Study completedNCT00092482
What this trial is testing

Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 3,882
Next Page